CXCL1 and head and neck cancer: Elevated CXCL1 levels in the blood of patients with head and neck cancer have been linked to radiation therapy failure [43], and higher CXCL1 expression in tumors is associated with a worse prognosis in head and neck squamous cell carcinoma [44].